UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20459





FORM 20-F





(Mark One)





o
ANNUAL REPORT PURSUANT TO SECTION 12 (b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934





OR





x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934





For the fiscal year-ended March 31, 2016





OR





o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934





OR





o
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934





Date of event requiring this shell company report _____________





For the transition period from _______________ to _____________





Commission File Number 0-53593





Dragon Jade International Limited


(Exact name of Registrant as specified in its charter)





___________________________________


(Translation of Registrant’s name into English)





British Virgin Islands


(Jurisdiction of incorporation or organization)





Unit 2, 23/F, New World Tower I, 18 Queens Road, Central Hong Kong, SAR, China


(Address of principal executive offices)





Lai Yat Man


Tel: 852 –3588-1780    Fax: 852 – 3005-6381


Unit 2, 23/F, New World Tower I, 18 Queens Road, Central Hong Kong, SAR, China


(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)





Securities registered or to be registered pursuant to Section 12(b) of the Act:  None





Securities registered or to be registered pursuant to Section 12(g) of the Act.


Common Stock, No Par Value Shares


(Title of Class)





Securities for which there is reporting obligation pursuant to Section 15(d) of the Act:  None.











i
 Table of Contents








Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.  51,063,319 shares of common stock, no par value.





Indicate by check mark if the registrant is a well-known season issuer, as defined in Rule 405 of the Securities Act.      o Yes      x No





If this report is an annual or  transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.      o Yes      x No





Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.





Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.      x Yes      o No





Indicate by check mark whether the registrant is a large accelerated filed, an accelerated filer, or a non-accelerated filer.  See definition of “accelerated filer and large accelerated filer”) in Rule 12b-2 of the Exchange Act.  (Check one):





Large accelerated filer     o
Accelerated filer     o
Non-accelerated filer     x





Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:





U.S. GAAP     x
International Financial Reporting Standards as issued by the International Accounting Standards Board     o
Other     o





If   “Other”  has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.     Item 17 o      Item 18 x





If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      o Yes      x No





(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)





Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 1, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.      o Yes      o No
































ii
 Table of Contents








TABLE  OF CONTENTS





PagePRELIMINARY NOTES
vPART IItem 1
Identity of Directors, Senior Management and Advisers
1Item 2.
Offer Statistics and Expected Timetable
1Item 3.
Key Information
2Selected financial data
2Currency exchange rates
2Capitalization and indebtedness
2Risk Factors
3Item 4.
Information on the Company
7History and development of the company
7Business overview
8Organizational structure
8Property, plants and equipment
8Item 5.
Operating and Financial Review and Prospects
9Item 6.
Directors, Senior Management and Employees
10Item 7.
Major Shareholders and Related Party Transactions
12Item 8.
Financial Information
13Item 9.
The Offer and Listing
13Item 10.
Additional Information
14Share capital
14Memorandum and articles of association
14Material contracts
14Exchange controls
14Taxation
15Dividends and paying agents
15Statement by experts
15Documents on display
15Item 11.
Quantitative and Qualitative Disclosures About Market Risk
15Foreign currency exchange rate sensitivityInterest rate sensitivityItem 12.
Description of Securities Other than Equity Securities
15PART IIItem 13.
Default, Dividend Arrearages and Delinquencies
15Item 14.
Material Modifications to the Rights of Security Holders and Use of Proceeds
15








iii
 Table of Contents








Item 15.
Controls and Procedures
16Item 16A.
Audit committee financial expert
17Item 16B.
Code of Ethics
17Item 16C.
Principal Accountant Fees and Services
17Item 16D.
Exemptions from the Listing Standards for Audit Committees
17Item 16E.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
17PART IIIItem 17.
RESERVED
17Item 18.
Financial Statements
17Item 19.
Exhibits
17Exhibit Index
18SIGNATURES
18








Pursuant to General Instruction E(b) of Form 20-F, this annual report includes the information specified in Parts I, II and III.





Pursuant to General Instruction E(c) of Form 20-F, the registrant has elected to provide the financial statements and related information specified in Item 18 in lieu of Item 17.
































iv
 Table of Contents








PRELIMINARY NOTE





Currencies:     We present our consolidated financial statements in United States dollars. All dollar amounts in this annual report on Form 20-F are stated in United States dollars ("US dollars", "$", or "US$"), except where otherwise indicated. Certain information in this Form 20-F is presented in Hong Kong dollars (“HK dollars” or HK$”).  See "Item 3. Key Information - Currency Exchange Rates" for a history of exchange rates of HK$ into US$.





Generally Accepted Accounting Principles:     We report our financial results using United States generally accepted accounting principles ("US GAAP").  Unless otherwise specified, all references to financial results herein are to those calculated under US GAAP.





Forward-Looking Information: This annual report contains “forward-looking statements.” Such forward-looking statements are subject to important risks, uncertainties and other factors, including those set forth under “Item 3.D. Risk Factors” and elsewhere in this annual report, that could cause actual results to differ materially from those stated in the  forward-looking statements.  Any statements in this annual report that are not statements of historical or current facts or conditions may be deemed “forward-looking” statements.  Forward-looking statements often may be identified by terminology such as “intend,” “should,” “expect,” “may,” “plan,” “anticipate,”  “believe,” “estimate,” “project,” “predict,” and the negative and variations of such words and comparable terminology.  While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment concerning future events, the risks and uncertainties involved in such forward-looking statements may cause actual results, performance and achievements to differ materially from any estimates, predictions, projections or plans about future events.  Statements containing forward-looking information are necessarily based upon a number of factors and assumptions that, while considered reasonable by us as of the date of such statements, are inherently subject to significant business and economic risks and uncertainties which may cause the actual results, performance or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as otherwise required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statements are based.




















v
 Table of Contents








PART I





Item  1.       Identity of Directors , Senior Management and Advisers





Our directors and senior management are:





LAW Lok Bun has served as President and a director of Dragon Jade International Limited since April 17, 2012 and as a director of Alpha Ultimate Ltd. since inception on April 11, 2012.





LAI Yat Man has served as Chief Executive Officer and a director of Dragon Jade International Limited since September 1, 2012 and as a director of United Asia Medical Network Co. Ltd. since inception on May 6, 1998.





FUNG Kwok Wing has served as Chief Financial Officer and a director of Dragon Jade International Limited since September 1, 2012.





LO Tsz Fung Philip has served as Independent Non-executive Director and a director of Dragon Jade International Limited since September 1, 2012.





TAI Tze Yu Daniel has served as Independent Non-executive Director and a director of Dragon Jade International Limited since September 1, 2012.





NGAI Wing Mui Phoenix has served as Secretary of Dragon Jade International Limited since June 22, 2012.





LAI Fan Wah (Thomas) has served as Independent Non-executive Director and a director of Dragon Jade International Limited since September 1, 2012 and resigned on May 4, 2016.





The business address of all our directors and senior management is Unit 2, 23/F, New World Tower I, 18 Queens Road Central, Hong Kong SAR, China.





Our principal bankers are:





The Hong Kong and Shanghai Banking Corporation Ltd., 1 Queen’s Road Central, Central, Hong Kong





Effective April 30, 2016, AWC (CPA) Limited (“AWC”) has merged (the “Merger”) with Dominic K.F. Chan & Co (“DKFC”) and formed DCAW (CPA) Limited (“DCAW”), which is registered with the Public Company Accounting Oversight Board (PCAOB).  As a result of the Merger, AWC resigned as the Company’s independent registered public accounting firm on April 30, 2016.  On May 5, 2016, the Company engaged DCAW (CPA) Limited, 7th Floor, Nan Dao Commercial Building, 359-361 Queen’s Road Central, Sheung Wan, Hong Kong, as its independent registered public accounting firm.








Item 2.       Offer Statistics and Expected Timetable





Not applicable.








1
 Table of Contents








Item 3.Key Information





A.
Selected financial data:  Dragon Jade International Limited (the “Company”) was incorporated on April 14, 2008 in the British Virgin Islands.  The principal activity of the Company is investment holding.



In April 2012, the Company chartered a new subsidiary, Alpha Ultimate Limited, under the laws of the Special Administrative Region of Hong Kong, which operates in the health supplement industry.



On August 31, 2012, the Company entered into a stock exchange agreement with United Century Holdings Limited, a privately held corporation. On September 1 2012, the Company consummated the transaction contemplated by that stock exchange agreement. All of the capital stock of United Century Holdings Limited was exchanged for an aggregate of 20,003,319 shares of the Company’s common stock. The Company became a 100% holding company of United Century Holdings Limited.



United Century Holdings Limited (“UCHL”) was incorporated on March 2, 2012 under the British Virgin Islands Business Companies Act, 2004 with limited liabilities. UCHL is established as a special purpose holding company whose objective is to become a holding company to consummate an acquisition, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses located in Hong Kong. On July 10, 2012, UCHL executed an acquisition of 7,879,500 out of 8,000,000 ordinary shares, par value $0.1282 (HK$1) per share, of the United Asia Medical Network Company Limited (“UAM”) and became a 98.49% holding company of UAM.



UAM was incorporated on May 6, 1998, as a limited liability company under Hong Kong Companies Ordinance, Chapter 32. Its principal business is the marketing and sale of health supplement products and providing related medical and health consultancy services.



The following table presents selected financial data for the fiscal year ended March 31, 2016, for the Company:



Revenues $336,906

Loss from operations (472,153)

Comprehensive gain 292,647

Stockholder’s equity (1,926,811)





Currency Exchange Rates.    All dollar amounts in this Form 20-F are in United States dollars.





B.  Capitalization and indebtedness:





The Company is authorized to issue 100,000,000 shares of common stock, no par value.  As of March 31, 2016, there were 51,063,319 issued and outstanding shares of common stock.





On December 31, 2012, the Company entered into definitive agreements relating to a private placement of $300,000 in principal amount of Convertible Notes due on December 31, 2013, and warrants to the purchasers of such Convertible Notes giving such purchasers the right to purchase up to an aggregate of 600,000 shares of our common stock at an exercise price of $0.50 per share.  At March 31, 2016, the outstanding principal and accrued interest under those Convertible Notes was $300,000.  On April 12, 2016, the Convertible Note was fully converted into 600,000 shares of our common stock. The outstanding principal of $300,000 was converted into 600,000 shares of our common stock at an exercise price of $0.50 per share in a transaction exempt from the registration and prospectus delivery requirements of the Securities Act of 1933.





On April 1, 2013, the Company entered into definitive agreements relating to a private placement of $100,000 in principal amount of Convertible Notes due on March 31, 2014, and warrants to the purchasers of such Convertible Notes giving such purchasers the right to purchase up to an aggregate of 200,000 shares of our common stock at an exercise price of $0.50 per share.  At March 31, 2016, the outstanding principal and accrued interest under those Convertible Notes was $100,000.





On April 11, 2014, the Company issued 450,000 shares of its common stock to 15 persons in transactions exempt from the registration and prospectus delivery requirements of the Securities Act of 1933, which exemption is specified by the provisions of Regulation S promulgated pursuant to the provisions of that act.  None of the recipients of those shares is a U.S. Person, as that term is defined by the provisions of Regulation S.  The Company received $450,000 from those persons as consideration for those shares.  Those shares were issued in off-shore transactions.  No directed selling efforts were made in the United States by the Company, any distributor, any of their respective affiliates or any person acting on behalf of the foregoing.








2
 Table of Contents








C. Reasons for the offer and use of proceeds.





Not applicable.





D. Risk Factor.  The following risk factors make the Company and our securities speculative and of high risk. Our business, operating results and financial position may be adversely affected by these risk factors, some of which we can’t control.  Additional risk factors not presently known by us or that we presently consider immaterial also could adversely affect our business, operating results and financial position, if any of them were to occur. In addition to these risk factors, shareholders and prospective investors should read the forward-looking statements about our future performance and expected results set forth in this annual report carefully before deciding to buy or sell our securities.  See “Forward-Looking Statements,” below.





Risks Related to Our Business





Our business is affected by global, national and local economic conditions, as the products we sell are discretionary. We depend upon factors relating to discretionary consumer spending in the East Asia. These factors include economic conditions, consumers, employment rates, the amounts of consumers' disposable income, business conditions, interest rates, consumer debt, availability of credit, and applicable taxation in regional and local markets where we sell our products. There can be no assurance that consumer spending for our products will not be adversely affected by changes in economic conditions.





Our ability to establish effective marketing and advertising campaigns is the key to our success. Our advertisements promote our products and the pricing of such products. If we are unable to increase awareness of our brands and our products, we may not be able to attract new customers. Our marketing activities may not be successful in promoting or pricing our products or retaining and enlarging our customer base. We cannot assure you that our marketing programs will be adequate to support our future growth, which may lead to material adverse effects on our results of operations.





Consumer preferences in the health care industry change rapidly and are difficult to predict. The success of our business depends on our ability to anticipate accurately and respond to future changes in consumer demand, maintain the correct inventory, deliver the appropriate products at the right prices and purchase at minimum costs. We must optimize our product selection and inventory based on consumer preferences and sales trends. If we fail to anticipate, identify or react appropriately to changes in consumer demand, we could experience excess inventories, higher than normal markdowns or be unable to sell the products, which will reduce our revenue, financial position and results of operations.





While we must maintain sufficient inventory to operate our business successfully and meet our customers' demands, we must be careful to not overstock. Changing consumer demands, manufacturer backorders and uncertainty surrounding new product launches expose us to increasing inventory risks. Demand for products can change rapidly and unexpectedly, including the back order time and availability for sale. We carry a wide variety of products and must maintain sufficient inventory amounts. We may be unable to sell certain products, in the event that consumer demand changes. Our inventory holding costs will increase, if we maintain excess inventory. However, if we do not have sufficient inventory to fulfill customer orders, we may lose orders or customers, which may adversely affect our business, financial condition and results of operations. We cannot assure you that we can accurately predict consumer demand and events and avoid over-stocking or under-stocking products.





We sell substantially all of our products by our distribution network, which is comprised of small distribution companies that are located in Hong Kong. Our ability to meet customer demand may be significantly limited, if we do not successfully operate our distribution network and logistics facilities, as well as efficiently conduct our distribution activities, or if one or more of our distribution companies or logistics facilities are destroyed or shut down for any reason, including as a result of a natural disaster. Any disruption in the operation of our distribution network could result in higher costs or longer lead times associated with distributing our products.




We may not be successful in expanding a distribution network. Although we intend to expand our distribution network including additional cities and rural areas in East Asia in an effort to increase our geographic appearance. Our distribution, logistics and products may encounter various competitions from similar or substitutive businesses. Therefore, the success of expansion will depend upon many factors, including our ability to form relationships with, and manage an increasing number of, customers base and optimize our distribution network. We must also be able to anticipate and respond effectively to competition. If we fail to expand our distribution network in East Asia as planned or if we are unable to compete effectively, our business, financial condition and results of operations may be materially and adversely affected.





All of our products are shipped using third-party carriers. If a strike or other event prevents or disrupts these carriers from transporting our products, other carriers may be unavailable or may not have the capacity to deliver our products. If adequate third-party sources to ship our products were unavailable at any time, our business would be materially adversely affected.








3
 Table of Contents








For our product distribution network, we engaged with a few small suppliers for a steady supply of products. We typically distribute products pursuant to annual agency or distribution agreements entered between us and our suppliers or upstream distributors, under which our suppliers provide us with a series of economic incentives and other support. We cannot assure you that manufacturers and other suppliers will continue to sell products to us on commercially reasonable terms, or at all. We also cannot ensure that we will be able to establish new manufacturer and other supplier relationships, or extend existing relationships with suppliers when our agreements with them expire. Our annual agency or distribution agreements with suppliers may be terminated from time to time due to various reasons beyond our control.





We do not directly own any land use rights in connection with the properties we rent. We may lose our rental properties or may not be able to renew leases for them on terms that are reasonable or favorable to us, when those leases expire. This may adversely impact our business, including disrupting our operations or increasing our cost of operations.





We will be exposed to risks inherent in the packaging and distribution of healthcare products, such as the unintentional distribution of counterfeit products. Furthermore, we may sell products which inadvertently have an adverse effect on the health of individuals. Product liability claims may be asserted against us, although we may have the right under applicable Hong Kong laws, rules and regulations to recover from the relevant manufacturer compensation we pay to our customers in connection with a product liability claim. Any product liability claim, product recall, adverse side effects caused by improper use of the products we sell or manufacturing defects may result in adverse publicity regarding us and the products we sell, which would harm our reputation. If we are found liable for product liability claims, we could be required to pay substantial monetary damages. Furthermore, even if we successfully defend ourselves against this type of claim, we could be required to spend significant management, financial and other resources, which could disrupt our business.





Any significant growth in the market for our products or our entry into new markets may require additional employees for managerial, operational, financial and other purposes. As of the date of this annual report, we had 10 full-time employees. During any growth, we may encounter problems related to our operational and financial systems and controls, including quality control and delivery and service capacities. We would also need to continue to expand, train and manage our employees. Continued future growth will impose significant added responsibilities upon our management to identify, recruit, maintain, integrate, and motivate new employees.





We may, also, encounter working capital shortage, as we may need additional funds to finance the purchase of materials and supplies, development of new products, and hiring of additional employees. For effective growth management, we will be required to continue improving our operations, management, and financial systems and controls. Our failure to manage growth effectively may lead to operational and financial inefficiencies, that will have a negative effect on our profitability. We cannot assure investors that we will be able to timely and effectively meet increased demand and maintain the quality standards required by our existing and potential customers.





If adequate additional financing is not available on reasonable terms, we may not be able to undertake our expansion plan or purchase additional equipment for our operations, and we would have to modify our business plans accordingly. There is no assurance that additional funds will be available to us.





We may experience increased capital requirements and, accordingly, we may not have sufficient capital to fund our future operations, without additional capital investments. Our capital needs will depend on numerous factors, including (i) our profitability; (ii) the release of competitive products by our competitors; and (iii) the amount of our capital expenditures, including acquisitions. We cannot assure you that we will be able to obtain capital in the future to meet our needs.





If we cannot obtain additional funds, we may be required to (i) limit our marketing efforts and (ii) decrease or eliminate capital expenditures. Such reductions could materially adversely affect our business and ability to compete.





We may not be able to negotiate terms and conditions for obtaining adequate funds that are acceptable to us. Any future capital investments could dilute or otherwise materially and adversely affect the holdings or rights of our existing shareholders. We cannot give you any assurance that any additional funds will be available to us or, if available, will be on terms favorable to us.








We will require substantial additional funding in the future. We have been dependent upon proceeds received from private equity and debt financing to meet our capital requirements in the past. In the future, we likely will require additional funding to meet our capital requirements for our health supplement and traditional Chinese medicine operations and to expand those operations. If we were unable to meet our future funding requirements for working capital and for general business purposes, we could experience operating losses and fail to expand our future operations. If so, our operating results, our business results and our financial position would be adversely affected.











4
 Table of Contents








We are dependent upon our senior management, particularly LAW Lok Bun and LAI Yat Man, to achieve profitability, and the loss of either one of them could have a material adverse effect upon our business, operating results and financial position. Our operating results and future success depend on our senior management’s services and our ability to retain members of our senior management or to replace any of them by attracting, hiring, retaining and motivating other highly skilled personnel who are experienced in managing, marketing and customer servicing. The loss of or inability to replace any member of our senior management could have a material adverse effect upon our business, operating results and financial position.





Our success is dependent upon our ability to compete in providing our health supplements and traditional Chinese medicine. In our industries, there is intense competition, including individuals and large and small entities. Many competitors have substantially greater financial and marketing resources than we do, stronger name recognition, and longer histories of operations. Our success is dependent upon our ability to compete, and our failure to do so could adversely affect our business, financial condition and results of operation.





Our operating results may fluctuate. Our operating results are dependent on a number of factors, many of which we do not control, including (i) the general economic conditions in Hong Kong, China and the world, (ii) the competition, and (iii) our ability to obtain necessary additional funds to maintain operations.





We are subject to certain requirements of the Sarbanes-Oxley Act of 2002 and the related rules and regulations adopted by the Securities Exchange Commission pursuant to that act. If we are unable to comply timely with such requirements or if the costs of compliance are too great, our profitability, the market price of our common stock, and our results of operations and financial condition could be materially adversely affected. The requirements, rules and regulations to which we are subject include Chief Executive Officer/Chief Financial Officer certifications of disclosure in periodic reports and annual reports under the Securities Act of 1933; disclosure regarding conclusions of evaluation of disclosure controls and procedures and internal control of financial reporting; conditions for use of non-GAAP financial measures; disclosure in Management’s Discussion and Analysis of certain off-balance sheet arrangements and aggregate contractual arrangements; disclosure of whether or not we have an audit committee financial expert who is independent and experienced, and if not, why not; and disclosure of whether or not we have adopted a written code of ethics for our Chief Executive Officer and senior financial officers, and if not, why not. These requirements involve substantial additional time and effort by our Chief Executive Officer/Chief Financial Officer and additional time, effort and expense for our auditors and counsel, as well as for us, all of whom are subject to potential liabilities for failure to comply with these requirements and some of whom may be unwilling or unable to satisfy these requirements.





Risks Related to Doing Business in China





Any change in government regulations or administrative practices in China and Hong Kong concerning our business may have a negative impact on our business, operating results and financial position. The laws, regulations and policies of the governments in China and Hong Kong and administrative practices in China, our principal jurisdiction, may be changed, applied or interpreted in a manner that will fundamentally alter our ability to carry on our business. The laws, regulations and policies of the government and the administrative practices in China, if changed, may have a detrimental effect on our business, operating results and financial position, resulting in our ability to promote our products and/or operate profitably.











5
 Table of Contents








Risks Related to Our Common Stock


Our common stock may be considered a “penny stock” under SEC rules, which would limit the market for our common stock and our ability to raise capital in an offering of our securities. If shares of our common stock are not listed on a national securities exchange or Nasdaq and do not have a minimum bid price of $5.00 per share, our common stock is considered a “penny stock,” as defined in Rule 3a51-1 of the Securities Exchange Act of 1934. SEC rules impose additional specific disclosure and other requirements on broker-dealers effecting transactions in penny stocks, which rules may reduce the market liquidity for our shares.





The Securities and Exchange Commission has adopted Rule 15g-9 for transactions in penny stocks which requires that:





In order to approve a person's account for transactions in penny stocks, the broker or dealer must:





●
obtain financial information and investment experience objectives of that person; and●
make a reasonable determination that transactions in penny stocks are suitable for that person and that person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.





The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to the penny stock market, which, in highlight form:





●
sets forth the basis on which the broker or dealer made the suitability determination;●
that the broker or dealer received a signed, written agreement from the investor prior to the transaction; and●
the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.





Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading; the commissions and other compensation payable to both the broker-dealer and the registered representative in connection with the penny stock transaction; current quotations for the penny stocks and other information relating to the penny stock market; and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in an account and information regarding the limited market in penny stocks.





Our three principal shareholders control us. None of our three principal shareholders holds a majority of our outstanding shares, which is required for the election of directors and other corporate action. But two of our three principal shareholders, Woody Fire Consultancy Limited (30.91%) and LAI Yat Man (24.70%), acting together, have a majority of our outstanding shares (55.61%) and, therefore, are able to elect all of the members of our board of directors. Those two shareholders, acting together, also are able to block any takeover bid or merger or acquisition proposal that may be beneficial to our other shareholders.





We have not paid and do not intend to pay cash or other dividends on our common stock. Rather, we expect that any earnings will be used in our operations and to finance the expansion of our business. Shareholders and investors in our company will not receive any cash or other dividends in the future and are advised to take this into consideration before making their investment decisions.





Other Risks





Enforcement of certain civil liabilities. We are a British Virgin Islands corporation doing business outside the United States, in Hong Kong and China. UCHL is a group of Hong Kong corporations doing business in Hong Kong. All of our officers and directors are residents of Hong Kong. All of our assets and those of our officers and directors are located outside the United States, in Hong Kong. Under these circumstances, shareholders and investors may not be able to effect service of process within the United States on such persons and may not be able to enforce against such persons judgments obtained in United States courts predicated on the civil liability provisions of the federal securities laws of the United States; moreover, it is unlikely that foreign courts would enforce, in original actions, liabilities against such persons predicated solely upon the federal securities laws of the United States. Neither the Company nor any of its subsidiaries or officers and directors presently has agreed to accept service of process in the United States or to abide by any judgments obtained in United States courts predicated upon the civil liability provisions of the federal securities laws of the United States, but all would possibly consider doing so in the future, based upon the facts and circumstances presented at that time.






6
 Table of Contents







The audit report included in this Annual Report was prepared by auditors who are not inspected by the Public Company Accounting Oversight Board and, as a result, you are deprived of the benefits of such inspection. The independent registered public accounting firm that issues the audit reports included in our annual reports filed with the SEC, as auditors of companies that are traded publicly in the United States and a firm registered with the Public Company Accounting Oversight Board (United States), or the “PCAOB”, is required by the laws of the United States to undergo regular inspections by the PCAOB to assess its compliance with the laws of the United States and professional standards. Because our auditors are located in the PRC, a jurisdiction where the PCAOB is currently unable to conduct inspections without the approval of the PRC authorities, our auditors are not currently inspected by the PCAOB. Inspections of other firms that the PCAOB has conducted outside China have identified deficiencies in those firms' audit procedures and quality control procedures, which may be addressed as part of the inspection process to improve future audit quality. The inability of the PCAOB to conduct inspections in China prevents the PCAOB from regularly evaluating our auditor's statements, audits and quality control procedures. As a result, investors may be deprived of the benefits of PCAOB inspections. The inability of the PCAOB to conduct inspections of auditors in China makes it more difficult to evaluate the effectiveness of our auditor's quality control and audit procedures as compared to auditors outside of China that are subject to PCAOB inspections. Investors may lose confidence in our reported financial information and procedures and the quality of our financial statements.







Item 4.      Other Information





A. History and Development of the Company


Dragon Jade International Limited (“Dragon Jade,” “the Company,” “we,” ”us”, “our” and similar terms) was incorporated in the British Virgin Islands, with limited liabilities on April 14, 2008.  When the Company was incorporated, its business plan was to engage in a merger or acquisition with a company with operations.  The Company is not and does not intend to be an “investment company,” as that term is defined in the Investment Company Act of 1940; in that, it is engaged and proposes to engage in business, by and through wholly owned or majority owned subsidiaries.





In April 2012, the Company chartered a new subsidiary, Alpha Ultimate Limited, under the laws of the Special Administrative Region of Hong Kong, which operates in the health supplement industry.





On August 31, 2012, the Company entered into a stock exchange agreement with United Century Holdings Limited, a privately held corporation.  On September 1, 2012, the Company consummated the transaction contemplated by that stock exchange agreement.  All of the capital stock of United Century Holdings Limited was exchanged for an aggregate of 20,003,319 shares of the Company’s capital stock.  As a result, the Company became a 100% holding company of United Century Holdings Limited.





United Century Holdings Limited (“UCHL”) was incorporated on March 2, 2012, under the British Virgin Islands Business Companies Act, 2004, with limited liabilities.  UCHL is established as a special purpose holding company, whose objective was to become a holding company by an acquisition, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more business located in Hong Kong.  On July 10, 2012, UCHL executed an acquisition of 7,879,500 out of 8,000,000 ordinary shares, par value $0.1282 (HK$1) per share, of the United Asia Medical Network Company Limited (“UAM”) and became a 98.49% holding company of UAM.





UAM was incorporated on May 6, 1998, as a limited liability company under Hong Kong Companies Ordinance, Chapter 32.  Its principal business is trading of health supplement products and providing related medical and health consultancy services.





Details of the Company’s subsidiaries (which together with the Company are collectively referred to as the “Group”) and their principal activities as of March 31, 2016 are as follows:




Name

Date of

incorporation/

establishment

Place of

incorporation/

registration and

operation

Percentage of

equity interest

attributable to

the Company


Principal activitiesAlpha Ultimate Ltd. (“AUL”)

April 11, 2012

Hong Kong


100
%

Health supplement tradingUnited Century Holdings Ltd. (“UCHL”)

March 2, 2012

BVI


100
%

Investment holdingUnited Asia Medical Network Company Limited (“UAM”)

May 6, 1998

Hong Kong


98.49
%

Health supplement trading





7
 Table of Contents








The principal executive offices of the Group are located at Unit 2, 23/F, New World Tower I, 18 Queens Road, Central Hong Kong, SAR, China; the telephone number is 852-3580 1788.  There is no agent for service in the United States, LAI Yat Man is the contact person for purposes of this Annual Report on Form 20-F.





B.  Business Overview


The Company engages in the health supplement business by and through Alpha Ultimate Ltd. (“AUL”) and United Asia Medical Network Company Limited (“UAM”), which sells health supplements (without any limitation or restriction as to customer size, industry or business).  UAM is a company incorporated in Hong Kong with a business network across Asia, including Hong Kong, mainland China, Taiwan, Japan, Korea, Singapore, Malaysia, and Thailand. UAM believes that, with its experience in human biological knowledge and marketing experience, it is able to provide beneficial nutritional products and medical services.  UAM operations include the unique combined use of traditional Chinese medicine and modern western medicine in treatment. Considering the adverse side effects of modern western medicine, the medical professionals of UAM believe that traditional Chinese medicine, with thousands of years of enhancement and empirical evidence, can complement western medicine, which will better serve patients.





In September 2015, AUL has begun to sell and distribute the Ultroid® Hemorrhoid Management System (“Ultroid® System”) in Hong Kong.  The Ultroid®System, which is FDA cleared and also approved for use in many other nations, is a non-surgical, non-anesthetic, and rapid treatment for hemorrhoidal disease (HD).  The Ultroid®System is unique to the market and currently the only FDA cleared device to treat and cure all four grades of internal and mixed hemorrhoids.The non-surgical technology is a break-through in painless hemorrhoid therapy requiring no anesthesia and no recuperation time.  Performed in the physician's office in minutes, patients are immediately able to resume their daily activities.





C. Organizational Structure







D. Property,Plants and Equipment





Except for some furniture and fixtures and office equipment, such as desks and chairs and computers, no member of the Group has any property.






8
 Table of Contents








Item 4A.     Unresolved Staff Comments





None.





Item 5.      Operating and Financial Review and Prospects.





The Company has realized gains totaling $292,647 for the fiscal year ending March 31, 2016, and had a retained earnings deficit of $3,030,772 as of March 31, 2016.





A.   Operating results.





Revenue for the fiscal year ended March 31, 2016 increased by $250,820 to $336,906 from $86,086 for the fiscal year ended March 31, 2015.  The increase in revenue was primarily due to sales of a new product called “Ultroid® Hemorrhoid Management System” commenced in September 2015.





Selling, general and administrative expenses totaled $713.956 for the fiscal year ended March 31, 2016, an increase of $194,695, or 37.5% from $519,261 for the fiscal year ended March 31, 2015. The increase in expenses was principally due to expenses related to the sales of “Ultroid® Hemorrhoid Management System”.





Our senior management, nevertheless, has determined to devote considerable efforts to marketing during the fiscal year ended March 31, 2016, in an attempt to generate new business. Management participated in more seminars for customers in Hong Kong, in order to get into contact with more potential customers. Efforts will also be spent to maintain friendly relationships with former customers, with the aim of acquiring new customers through referrals.





B.   Liquidity and capital resources.





As of March 31, 2016, the Company had a working capital deficiency of $1,970,798 and cash of $18,806. This compares with working capital deficiency of $2,237,622 and cash of $29,136 as of March 31, 2015. The Company estimates its working capital needs for the next 12 months to be approximately $1,000,000.  As of March 31, 2016, it had insufficient funds on hand to meet such needs.





On December 31, 2012, The Company entered into definitive agreements relating to a private placement of $300,000 in principal amount of Convertible Notes due on December 31, 2013, and warrants to the purchasers of such Convertible Notes giving such purchasers the right to purchase up to an aggregate of 600,000 shares of our common stock at an exercise price of $0.50 per share.  At March 31, 2016, the outstanding principal and accrued but unpaid interest under those Convertible Notes was $300,000.  On April 12, 2016, the Convertible Note was fully converted into 600,000 shares of our common stock. The outstanding principal of $300,000 was converted into 600,000 shares of our common stock at an exercise price of $0.50 per share in a transaction exempt from the registration and prospectus delivery requirements of the Securities Act of 1933.





On April 1, 2013, the Company entered into definitive agreements relating to a private placement of $100,000 in principal amount of Convertible Notes due on March 31, 2014, and warrants to the purchasers of such Convertible Notes giving such purchasers the right to purchase up to an aggregate of 200,000 shares of our common stock at an exercise price of $0.50 per share.  At March 31, 2016, the outstanding principal and accrued interest under those Convertible Notes was $100,000.





On April 11, 2014, the Company issued 450,000 shares of its common stock to 15 persons in transactions exempt from the registration and prospectus delivery requirements of the Securities Act of 1933, which exemption is specified by the provisions of Regulation S promulgated pursuant to the provisions of that act.  None of the recipients of those shares is a U.S. Person, as that term is defined by the provisions of Regulation S.  The Company received $450,000 from those persons as consideration for those shares.  Those shares were issued in off-shore transactions.  No directed selling efforts were made in the United States by the Company, any distributor, any of their respective affiliates or any person acting on behalf of the foregoing.





The Company estimates its working capital needs for the next 12 months to be approximately $1,000,000.  As of March 31, 2016, it had insufficient funds on hand to meet such needs. The Company’s major shareholders will continue to provide financial support to the Company to meet its working capital needs for the next 12 months.  The Company intends on funding its future development activities needs from the sale of equity securities, with some additional funding from other sources.





C.   Research and development, patents and licenses, etc.





Not Applicable.








9
 Table of Contents








D.   Trend information.





We expect the serious financial crisis in the United States and elsewhere in the world to continue to adversely affect our business and, therefore, our results of operation during the calendar year 2016.  We anticipate that we will continue to reduce our expenses and look to our directors to provide funds necessary to meet our obligations.  We also may consider making an offering of our securities to raise capital, in the United States and/or in China and Hong Kong.





On May 5, 2016 the Company entered into a memorandum of understanding with Ultroid Marketing Development Corporation (“UMDC”) for a proposed definitive agreement to be signed within one hundred and twenty days in which the Company acquires one hundred percent interest in UMDC.  The contemplated definitive agreement proposes the Company to acquire UMDC for $40,000,000 in a combination of cash and DGJI common stock.  Ultroid Marketing Development Corporation, a technology company based in Florida, United States, manufactures and markets Ultroid® Hemorrhoid Management System (“Ultroid® System”).  The Ultroid®System, which is FDA cleared and also approved for use in many other nations, is a non-surgical, non-anesthetic, and rapid treatment for hemorrhoidal disease (HD).  The Ultroid®System is unique to the market and currently the only FDA cleared device to treat and cure all four grades of internal and mixed hemorrhoids.The non-surgical technology is a break-through in painless hemorrhoid therapy requiring no anesthesia and no recuperation time.  Performed in the physician's office in minutes, patients are immediately able to resume their daily activities.





E.  Off-balance sheet arrangements





Not Applicable.





F.   Tabular disclosure of contractual obligations





Not Applicable.





Item 6.      Directors, Senior Management and Employees





A. Directors and senior management.   Our directors and senior management are:





Mr. Law Lok Bun, age 64, is an Executive Director and the President of the Company. He was appointed as an Executive Director of the Company on April 17, 2012. He is responsible for planning the overall direction of the Company and managing the Company's day to day affairs. He has more than thirty years of experience in pharmaceutical manufacturing, wholesaling and retail operations. He is, currently, a managing director of Merika Medicine Factory Limited. Mr. Law is a graduate of Hong Kong Baptist University, from which he received a B.A. Degree in Analytical Chemistry.





Dr. Lai Yat Man, age 56, is an Executive Director and the Chief Executive Officer of the Company. He was appointed as an Executive Director of the Company on September 1, 2012. He is primarily responsible for the Company’s business planning, strategy and management, as well as providing medical and biological information support. He has more than 25 years of experience in the medical and pharmaceutical industries. From 1987 to 1988, he served as the Chief Resident of Emergency Internal Medicine Department of Neihu General Hospital in Taipei. From 1988 to 1995, he served as the Chief of Internal Medicine Department of Tamsui First Hospital in Taipei County. In 1998, he founded United Asia Medical Network Company Limited in Hong Kong. He is, currently, the Chairman of United Asia Medical Network Company Limited. Dr. Lai received his medical degree from the Medical College of National Taiwan University in 1985.





Mr. Fung Kwok Wing, age 42, is an Executive Director and the Chief Financial Officer of the Company. He was appointed as an Executive Director of the Company on September 1, 2012. He is primarily responsible for the business operations, developing the financial strategy, overseeing financial and administrative operations, and the human resources management of the Company. He has more than 10 years of experience in accounting and finance. He is, also, currently, the Chief Financial Officer of United Asia Medical Network Company Limited. Mr. Fung is a member of the American Institute of Certified Public Accountants. Mr. Fung obtained a Bachelor of Social Science in Economics Degree from The Chinese University of Hong Kong in 1995.





Mr. Lo Tsz Fung Philip, age 50, was appointed as an Independent Non-executive Director of the Company on September 1, 2012. Mr. Lo was appointed as a director and the Chairman of the Audit Committee and a member of the Compensation Committee and Corporate Governance Committee of QKL Stores Inc. (NASDAQ: QKLS )in November 2011. Mr. Lo has served as managing director of Shenzhen Xin Wei Managing Consultancy Limited since August 2011, independent non-executive director of Styland Holdings Limited (Hong Kong Exchange Code: 211) since April 2009, and managing director of P&L Financial Consultancy Limited since December 2007. Mr. Lo, also, served as Chief Financial Officer of Wuhan General Group (China) Inc. (NASDAQ: WUHN) from February 2010 to January 2012; Chief Financial Officer of Wuhan Zhongye Yangluo Heavy Machinery Co., Ltd. from December 2007 to January 2009; and Senior Manager of Albert Wong & Co, from June 2006 to December 2007. Mr. Lo received his Bachelor’s Degree from University of Wollongong, Australia. He is a member of CPA Australia and a member of HKICPA. We believe that Mr. Lo’s knowledge of finance and accounting matters brings a unique expertise to our Board of Directors.






10
 Table of Contents








Mr. Lai Fan Wah (Thomas), age 59, was appointed as an Independent Non-executive Director of the Company on September 1, 2012 and resigned on May 4, 2016. Mr. Lai has been a director of Trinergy M&A Advisory Limited since 2010, which is a merger and acquisition advisory firm located in Shanghai, serving the greater China market. Mr. Lai was the Marketing Manager of Chong Hing Securities Company Limited, a wholly-owned subsidiary of Chong Hing Bank Limited Hong Kong from 2007 to 2008. Mr. Lai served as an Investment Advisor of HSBC Securities (Canada) Inc. in Toronto, Canada from 2001 to 2004; as a wholly-owned subsidiary of HSBC Bank Canada, the firm provided private banking services for clients of HSBC Bank Canada. Mr. Lai graduated from the Arts Department of Hong Kong Shue Yan College, was awarded MBA Degree from Oklahoma City University, Oklahoma, USA and Bachelor in Laws Degree from the Peking University, Beijing, Peoples’ Republic of China. We believe that Mr. Lai’s knowledge of banking and financing matters brings a unique expertise to our Board of Directors.





Mr. Tai Tze Yu Daniel, age 55, was appointed as an Independent Non-executive Director of the Company on September 1, 2012. He has more than 20 years of management and supervision experience in various enterprises, which engage in the businesses of electronic products, catering and trading. From 1990 to 2006, he was a Manager and General Manager of Sharp-Roxy (HK) Limited in Hong Kong. He was primarily responsible for the planning, direction and control of all sales, advertising and promotion activities related to consumer electronic products. In addition to the local sales in Hong Kong, he had full responsibility and accountability of the corporate sales, sales administration and support, and new business development. From 2006 to 2007, he was a manager and director of Rakutei Dinning & Bar. From 2007 to 2009, he was a General Manager of Kelvin Electric Trading Company Limited. He is, currently, a Managing Director of Aqua Gold Holding Company Limited since 2009.  From 2003 to the present, Mr. Tai has served as a Director and Executive Director of Radio Association of Hong Kong. He was the Fellow of The Professional Validation Centre of Hong Kong Business Sector in 2005.





There is no family relationship between any of the directors and officers of the Company or AUL or UCHL or UAM.





B. Compensation.





The Company has paid and will pay each independent director annual compensation of US$1,500. None of our officers and none of our non-independent directors receive any compensation from the Company.  Also, all of our officers and directors are entitled to receive compensation from UAM for services rendered to UAM.





None of the members of our senior management receives any other form of remuneration, such as bonuses, stock awards, stock options, or benefits, such as country club memberships or automobiles.





No amounts were set aside or accrued by UAM to provide pension, retirement or similar benefits to senior management.





C.   Board Practices.





The current terms of office of our directors expire at the next annual meeting of our shareholders, when their successors are elected and qualified.





There, currently, is no agreement as to compensation to be paid to the executive officers who, also, serve as non-independent directors (LAW Lok Bun, LAI Yat Man and FUNG Kwok Wing).  Each of such executive officers / directors has other employment, and provides services to the Company on an as-needed basis. The Company has not accrued salary to these persons, issued shares as compensation, issued stock options or warrants, or recorded contributed capital for the services provided by them and no employment agreements exist. The Company is not aware of any accounting pronouncement that requires the compensation of executive officers / directors (other than for certain non-profit organizations) who provide executive services on an as-needed basis.





Our board of directors maintains an Audit Committee.  Lo Tsz Fung Philip serves as the chairman, and Tai Tze Yu Daniel serve as members of the Audit Committee. Lo Tsz Fung Philip is an “audit committee financial expert” as defined by the rules of the NASDAQ Stock Market, Inc. and Rule 10A-3(b)(i) under the Securities Exchange Act of 1934, applicable to members of an audit committee.  The Audit Committee is appointed by our board of directors to assist our board of directors in monitoring (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, and (3) the independence and performance of our internal and external auditors.





D.   Employees.





As of March 31, 2016, we had 10 full-time employees.  As of that date, none of our employees were represented by a labor union.






11
 Table of Contents








E.   Share Ownership.





The shares of the Company that are beneficially owned by LAW Lok Bun, LAI Yat Man and Woody Fire Consultancy Limited “control” the Company, because of their shareholdings and related management positions. The following table sets forth, as of March 31, 2016, the beneficial ownership of shares of the common stock of the Company beneficially owned by (1) each person known to be the beneficial owner of more than 5% of our shares of our common stock and (2) each of the members of senior management identified in Item 6.A., above.  (The term “beneficial owner” of securities refers to any person who, even if not the record owner of the securities, has or shares the underlying benefits of ownership. These benefits include the power to direct the voting or disposition of the securities or to receive the economic benefit of ownership of the securities.  A person also is considered to be the “beneficial owner” of securities that such person has the right to acquire within 60 days by option or other agreement.  Beneficial owners include persons who hold their securities through one or more trustees, brokers, agents, legal representatives or other intermediaries, or through companies in which they have a “controlling interest,” which means the direct or indirect power to direct the management and policies of the entity.)





NAME

SHARES OWNED


PERCENT OF CLASSWoody Fire Consultancy Limited*


15,500,000



30.35Lai Yat Man


12,762,804



24.99Law Lok Bun


7,000,000



13.71Fung Kwok Wing


-



-Lo Tsz Fung Philip


-



-Lai Fan Wah (Thomas)


-



-Tai Tze Yu Daniel


-



-Officers & Directors as a Group (6 persons)


19,762,804



38.70
%* LO Hsin Yu is the shareholder of and has a controlling interest in Woody Fire Consultancy Limited.





There is no arrangement involving any person named in the table that involves the issue or grant of options for our shares or any shares.





Item 7.      Major Shareholders and Related Party Transactions





A.   Major Shareholders. As of March 31, 2016, our major shareholders, LAW Lok Bun, LAI Yat Man and Woody Fire Consultancy Limited, beneficially own, respectively, 7,000,000 shares of the Company’s common stock, or 13.71%, 12,762,804 shares or 24.99% and 15,500,000 shares or 30.35%.  See Item 6.E., above.  On April 15, 2012, the shareholders of the Company entered into a Purchase and Sales Agreement with a group led by LAW Lok Bun to acquire 27,910,000 issued shares of the Company’s common stock. That agreement, also, provided that Mr. Law be elected to the Board of Directors and the Company charter a new subsidiary, Alpha Ultimate Limited, under the laws of the Special Administrative Region of Hong Kong, which will operate in the traditional Chinese medicine industry. The transaction closed on June 22, 2012.  On September 1, 2012, the Company acquired 100% of the total issued shares of UCHL capital stock from its original shareholders, in exchange for an aggregate of 20,003,319 shares of the Company’s common stock.





None of our 51,063,319 issued and outstanding shares of common stock as of March 31, 2016, is held by persons in the United States.  We are not, directly or indirectly, owned or controlled by another corporation, by any foreign government, or by any other natural or legal person, severally or jointly. We know of no arrangement the operation of which may at a subsequent date result in a change in control.





Our shareholders do not have different voting rights.





B.   Related Party Transactions.   Since April 1, 2012, there has been no related party transaction, except the amount of $729,609 due LAI Yat Man for funds advanced to the Company, AUL and UAM, which amount has no due date or maturity date and does not accrue any interest. (Related party transactions are transactions or loans between the Company and (a) enterprises directly or indirectly controlled by the Company; (b) associates of our major shareholders; (c) our major shareholders; (d) our senior management or (e) entities directly or indirectly controlled by our major shareholders or senior management.)





C.  Interests of experts and counsel.   No counsel or accountant for the Company has been employed on a contingent basis or owns shares of common stock of the Company or of AUL, UCHL, or UAM.






12
 Table of Contents








Item 8.      Financial Information





A. Consolidated Statements and Other Financial Information





The following consolidated financial statements and other financial information are included as part of this Annual Report, after “Signatures”:





Dragon Jade International Limited.


Consolidated Balance Sheets as of March 31, 2016 and 2015


Consolidated Statements of Operations and Comprehensive Loss for the years ended March 31, 2016 and 2015.


Consolidated Statements of Cash Flow for the years ended March 31, 2016 and 2015.


Consolidated Statements of Change in Stockholders Equity (Deficit) for the years ended March 31, 2016 and 2015.


Notes to Consolidated Financial Statements





B.   Significant Changes.





None.





Item 9.      The Offer and Listing





A.   Offer and listing details.





The initial bid and asked prices submitted for quotation by the sponsoring broker-dealer are determined arbitrarily by negotiation between that broker-dealer and us and may not necessarily have any relationship to our asset value, earnings, financial condition or other established criteria of value; such prices will be subject to change, as a result of market conditions and other factors.





The prices of our shares of common stock are quoted on the OTC Bulletin Board.  The OTC Bulletin Board is a significantly more limited market than the New York Stock Exchange or NASDAQ system.  The quotation and the prices of our shares of common stock on the OTC Bulletin Board may result in a less liquid market available for existing and potential stockholders to trade shares of our common stock and could depress the trading price of our common stock and have a long-term adverse impact on our ability to raise capital in the future.





When fewer shares of a security are traded on the OTCBB, volatility of prices may increase and price movement may outpace the ability to deliver accurate quote information.  Due to lower trading volumes in shares of our common stock, there may be a lower likelihood of a person’s orders for shares of our common stock being executed, and current prices may differ significantly from the price one was quoted at the time of a person’s order entry.





The transfer agent for our shares of common stock is Pacific Stock Transfer Company, 6725 Via Austi Pkwy, Suite 300, Las Vegas, NV 89119.





B.  Plan of distribution.   Not applicable.





C.  Markets.





See Item 9.A., above.





D.  Selling shareholders.   Not applicable.





E.  Dilution.   Not applicable.





F. Expenses of the issue.   Not applicable.






13
 Table of Contents








Item 10.    Additional Information





A.   Share capital. Pursuant to Section 6.1 of our Memorandum of Association, we are authorized to issue 100,000,000 shares of no par value common stock.  As of March 31, 2016, our recent fiscal year end, 51,063,319 of our authorized shares of common stock were issued and outstanding,  As of July 25, 2016, the latest practical date, 51,663,319 of our authorized shares of common stock were issued and outstanding,  Pursuant to Section 7 of our Memorandum of Association, holders of our common stock are entitled to one vote per share on each matter submitted to a vote of our shareholders, the right to an equal share in any dividend paid by the Company, and the right to an equal share in the distribution of surplus assets, if any, on liquidation of the Company.  Holders of our common stock do not have preemptive rights to purchase additional shares of our common stock or other subscription rights.  Our common stock has no conversion rights and is not subject to redemption or any sinking fund provisions.  All shares of our common stock are entitled to share equally in dividends from legally available sources, as determined by the board of directors.  Upon dissolution or liquidation of the Company, whether voluntary or involuntary, holders of our common stock are entitled to receive assets of the Company available for distribution to our shareholders.





There were no changes in voting rights involved in this transaction.





B.   Memorandum and Articles of Association.





(1)  The Company was incorporated under the Territory of the British Virgin Islands BVI Business Companies Act 2004, on April 14, 2008.  Section 5.1 of our Memorandum of Association provides that the Company has full capacity to carry on or undertake any business or activity, do any act and enter into any transaction.





(2)  Section 8 of our Articles of Association provides that the minimum number of directors shall be one; there is no maximum number of directors.  There are no limitations or restrictions on the borrowing power of directors; there are no age limit requirements and no shareholding requirements.





Section 13 of our Articles of Association, concerning conflicts of interest, provides that a director shall disclose that he is interested in a transaction entered into or to be entered into by the Company and such director may vote on a matter relating to such transaction, attend a meeting of directors relating to such transaction, and sign a document on behalf of the Company or do anything in his capacity as a director that relates to such transaction.





(3)  Section 18 of our Articles of Association provides that our directors may authorize a distribution by way of dividend at any time, if they are satisfied that immediately after such distribution the value of the Company’s assets will exceed its liabilities and the Company will be able to pay its debts as they become due.  Section 7 of our Memorandum of Association provides that each share of our common stock is entitled to one vote at a meeting of our shareholders or on any resolution of our shareholders; share equally in any dividend paid by the Company; and share equally in the distribution of any surplus assets of the Company on its liquidation.  There are no pre-emptive rights.





(4)  Section 8 of our Articles of Association provides that the rights of our shareholders may be varied with the consent in writing, or by resolution passed at a meeting, by holders of more than 50% of our issued shares of our common stock.





(5)  Section 7 of our Articles of Association provides that any director may convene a meeting of our shareholders and our shareholders entitled to exercise 30% or more of the voting rights may request directors in writing to convene a meeting of our shareholders.





(6)  There are no limitations or restrictions on the rights of non-resident or foreign shareholders to own shares of our common stock or to hold or exercise voting rights.





(7)  There are no provisions that would have an effect of delaying, deferring or preventing a change in control of the Company.





(8)  There are no provisions governing the threshold above which shareholder ownership must be disclosed.





C.   Materialcontracts. There have been no material contracts since the formation of the Company.





D.   Exchange controls. Neither the British Virgin Islands nor Hong Kong has any system of exchange controls, and there is no restriction of any kind on the repatriation of capital or the remittance of dividends, profits, interests, royalties or other payments to non-resident holders of the Company’s securities.








14
 Table of Contents








E.    Taxation.  Shareholders will not be subject to taxation, including withholding provisions, in the British Virgin Islands or Hong Kong.  The Company assumes no responsibility for the withholding of any tax upon the payment of dividends, and there is no tax treaty between the British Virgin Islands and the United States regarding such withholding.





The Company is subject to applicable taxes in Hong Kong, but our shareholders are exempt.





There is no tax treaty between the United States and Hong Kong.





For United States federal income tax purposes, the gross amount of all distributions paid with respect to our common stock to a person subject to United States federal income taxation, generally, will be treated as foreign source dividend income to such person.  Gain or loss from the sale of shares of our common stock, generally, will be subject to federal income taxation at a maximum federal income tax rate from 15% to 20%, if that common stock was held for more than 12 months or as ordinary income, if that common stock was held for less than 12 months.





G.   Statement by experts.  The auditors of the Company are DCAW (CPA) Limited, 7th Floor, Nan Dao Commercial Building, 359-361 Queen’s Road Central, Sheung Wan, Hong Kong.  The financial statements included as part of this Annual Report have been included herein in reliance upon the authority of such auditors, as experts in accounting and auditing.





H.   Documents on display. Item 19 sets forth a list of exhibits; that list is incorporated herein by reference.





I.   Subsidiary information. Information concerning AUL, UCHL, and UAM, our subsidiaries, is included throughout this Annual Report; AUL’s, UCHL’s, and UAM’s financial statements, also, are included.





Item 11.    Quantitative and Qualitative Disclosures About Market Risk





We have not entered into market risk sensitive instruments for any purpose.





Item 12.    Description of Securities Other than Equity Securities.





Not applicable.





PART II





Item 13.    Defaults, Dividend Arrearages and Delinquencies





There has not been a material default in the payment of principal or interest relating to our indebtedness.





We have not paid any dividends.





Item 14.    Material Modifications to the Rights Of Security Holders And Use of Proceeds





The rights of the holders of our common stock have not been modified or qualified by any instrument defining such rights or the issuance of any other securities.








15
 Table of Contents








Item 15.    Controls and Procedures





Evaluation of disclosure controls and procedures





The Company's management, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company's disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934 (the “Exchange Act”).  In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must anticipate the fact that there are resource constraints and management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.





Based on such evaluation, the Company's Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2016, the Company's disclosure controls and procedures are designed at a reasonable assurance level and effective to provide reasonable assurance that information the Company is required to disclose in reports that the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and such information is accumulated and communicated to the Company's management, including the Company's Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.





Management's report on internal control over financial reporting





Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting.  Internal control over financial reporting is a process designed by, or under the supervision of, the Company's Chief Executive Officer and Chief Financial Officer and effected by the Company's Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.  Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate, because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.





The Company's management, including the Company's Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of the Company's internal control over financial reporting criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework.  Based upon its assessment, management, including the Company’s Chief Executive Officer and Chief Financial Officer, concluded that, as of March 31, 2016, the Company's internal control over financial reporting was effective.





Attestation report of the registered public accounting firm. This annual report does not include an attestation report of the Company's public accounting firm regarding internal control over financial reporting.  Management's evaluation was not subject to such attestation report pursuant to temporary rules of the Securities and Exchange Commission that permit the Company to report only management's evaluation on this annual report.





Changes in internal control over financial reporting.   Management regularly reviews its system of internal control over financial reporting and makes changes to the Company's processes and systems to improve controls and increase efficiency, while ensuring that the Company maintains an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, consolidating activities, and migrating processes.





There were no changes in the Company's internal control over financial reporting that occurred during the period covered by this Annual Report that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.





The Company will continue to periodically review its disclosure controls and procedures and internal control over financial reporting and may make modifications from time to time as considered necessary or desirable.





Item 15T.   Controls and Procedures





Not Applicable.






16
 Table of Contents








Item 16 .    [Reserved]





Item 16A.  Audit committee financial expert





Our board of directors maintains an Audit Committee.  Lo Tsz Fung Philip serves as the chairman, and Tai Tze Yu Daniel, serve as members of the Audit Committee. Lo Tsz Fung Philip is an “audit committee financial expert” as defined by the rules of the NASDAQ Stock Market, Inc. and Rule 10A-3(b)(i) under the Securities Exchange Act of 1934 applicable to members of an audit committee.  The Audit Committee is appointed by our board of directors to assist our board of directors in monitoring (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, and (3) the independence and performance of our internal and external auditors.





Item 16B.  Code of Ethics





We haven’t adopted a code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, but expect to do so before March 31, 2017.





Item 16C.  Principal Accountant Fees and Services





Audit Fees: The aggregate fees for each of the two fiscal years ended March 31, 2016, and March 31, 2015, for professional services rendered by DCAW (CPA) Limited, 7th Floor., Nan Dao Commercial Building, 359-361 Queen’s Road Central, Sheung Wan, Hong Kong, for the fiscal year ended March 31, 2016, and AWC (CPA) Limited, 7th Floor., Nan Dao Commercial Building, 359-361 Queen’s Road Central, Sheung Wan, Hong Kong, for the fiscal year ended March 31, 2015, our principal accountants for the audit of our annual financial statements, were $14,000 for the fiscal year ended March 31, 2016, and $13,000 for the fiscal year ended March 31, 2015.





Audit-Related Fees: DCAW (CPA) Limited did not perform or bill for any audit-related services during the fiscal year ended March 31, 2016. AWC (CPA) Limited did not perform or bill for any audit-related services during the fiscal year ended March 31, 2015.





Tax Fees:   DCAW (CPA) Limited did not render or bill for any services relating to tax compliance, tax advice or tax planning during the fiscal year ended March 31, 2016. AWC (CPA) Limited did not render or bill for any services relating to tax compliance, tax advice or tax planning during the fiscal year ended March 31, 2015.





All Other Fees: DCAW (CPA) Limited did not provide any products or other services during the fiscal year ended March 31, 2016. AWC (CPA) Limited did not provide any products or other services during the fiscal year ended March 31, 2015.





Item 16D.  Exemptions from the Listing Standards for Audit Committees.





Not Applicable.





Item 16E.   Purchase of Equity Securities by the Issuers and Affiliated Purchasers





None of our shares was purchased by us or an affiliated purchaser, such as an officer or director during the last fiscal year.





PARTIII





Pursuant to General Instruction E(c) of Form 20-F, the Company has elected to provide the financial statements and related information specified in Item 18 in lieu of Item 17.





Item 17.    Reserved





Item 18.    Financial Statements





The financial statements and other financial information included in this Annual Report are listed in Item 8, above, and are incorporated herein by reference.





Item 19.    Exhibits





Exhibits and Exhibit Index. The following Exhibits are filed as part of this Annual Report as amended or incorporated by reference to the same exhibit number in either (1) the annual report on Form 20FR12G or an amendment thereto, or (2) this annual report on Form 20-F or an amendment thereto, as specified in the footnotes to the Exhibit Index below.






17
 Table of Contents








Exhibit Index





Exhibit No.

Description1*

Memorandum and Articles of Association2*

Specimen Common Stock Certificate8*

Subsidiaries12.1**

Certificate of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.12.2**

Certificate of Chief Financial Officer Pursuant to Section 302 0f the Sarbanes-Oxley Act of 2002.13.1**

Certification of Chief Executive Officer Pursuant to Title 18, United States Code, Section 135013.2**

Certification of Chief Financial Officer Pursuant to Title 18, United States Code, Section 1350





*
Previously filed.





**
Filed herewith.





SIGNATURES





The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.





DRAGON JADE INTERNATIONAL LIMITEDHong Kong, July 25, 2016
By:
/s/ Lai Yat ManLai Yat Man, Chief Executive OfficerBy:
/s/ Fung Kwok WingFung Kwok Wing, Chief Financial Officer










18
 Table of Contents














DRAGON JADE INTERNATIONAL LIMITED





CONSOLIDATED FINANCIAL STATEMENTS








March 31, 2016





Together With Report Of





Independent Registered Public Accounting Firm















































19
 Table of Contents








DRAGON JADE INTERNATIONAL LIMITED





INDEX TO CONSOLIDATED FINANCIAL STATEMENTS





Consolidated Balance Sheets
22Consolidated Statements of Operations
23Consolidated Statements of Changes in Stockholders’ Deficit
24Consolidated Statements of Cash Flows
25Notes to Consolidated Financial Statements
26-36















































20
 Table of Contents








DCAW (CPA) LIMITEDCERTIFIED PUBLIC ACCOUNTANTS7th Floor, Nan Dao Commercial Building,359-361 Queen’s Road Central, Sheung Wan,Hong KongTel : (852) 2851 7954Fax: (852) 2545 4086








To: The board of directors and stockholders of


Dragon Jade International Limited and Subsidiaries





Report of Independent Registered Public Accounting Firm





We have audited the accompanying consolidated balance sheet of Dragon Jade International Limited and subsidiaries (“the Company”) as of March 31, 2016 and 2015 and the related consolidated statements of income, stockholders’ equity and cash flow for the year then ended. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audit.





We conducted our audit in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.





We were not engaged to examine management’s assertion about the effectiveness of the Company’s internal control over financial reporting as of March 31, 2016 included in the Company’s Item 15 “Controls and Procedures” in the Annual Report on Form 20-F and, accordingly, we do not express an opinion thereon.





In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Dragon Jade International Limited as of March 31, 2016 and 2015, and the results of its operations and its cash flow for the year then ended in conformity with accounting principles generally accepted in the United States of America.





The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2(q) to the financial statements, the Company has suffered losses from operations and has a significant accumulated deficit. In addition, the Company comes to have insufficient cash flows from operations and for development. These factors raise substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.








/s/ DCAW (CPA) LIMITED





DCAW (CPA) LIMITED


Certified Public Accountants


Hong Kong, China


July 25, 2016











21
 Table of Contents








DRAGON JADE INTERNATIONAL LIMITED





Consolidated Balance Sheet





March 31,


March 31,2016


2015AssetsCurrent assetsCash and Bank Deposits

$
18,806


$
29,136Trade receivable


40,492



15,003Deposit & Prepayments


15,212



7,166Inventory


191,992



1,950Total current assets


266,502



53,255Plant, machinery and equipment, net


24,083



3,023Total assets


290,585



56,278Liabilities and stockholders’ equityCurrent liabilitiesAccounts Payable


20,317



10,936Amount due to Directors


729,609



51,788Accruals & Other payable


47,374



28,153Convertible promissory note


1,440,000



2,200,000Total current liabilities


2,237,300



2,290,877Stockholders' equityCommon stock, 100,000,000 shares authorized and 51,063,319 shares and 51,063,319  shares issued at no par value at March 31, 2016 and March 31, 2015 respectively


1,103,961



1,103,961Common shares to be issued


-



-Retained earnings


(3,030,772
)


(3,323,419
)Other Comprehensives Income


-



-Total stockholders' equity


(1,926,811
)


(2,219,458
)Non-controlling interest


(19,904
)


(15,141
)Total liabilities and stockholders' equity

$
290,585


$
56,278











22
 Table of Contents








DRAGON JADE INTERNATIONAL LIMITED





Consolidated Statement of Operations and Comprehensive Loss






For the Years Ended March 31,2016


2015


2014Revenue

$
336,906


$
86,086


$
327,764Costs of revenues


(95,103
)


(32,186
)


(155,616
)Gross profits


241,803



53,900



172,148ExpensesSelling, general and administrative


(713,956
)


(519,261
)


(582,643
)Income/(loss) from operations


(472,153
)


(465,361
)


(410,495
)Other income


37



283



8,514Gain/(Loss) on change in fair value of convertible note liability


760,000



(1,383,992
)


(520,130
)Total other income/(loss)


760,037



(1,383,709
)


(511,616
)Gain/(Loss) before income tax


287,884



(1,849,070
)


(922,111
)Income tax


-



-



(226,016
)Non-controlling interest


4,763



6,158



7,008Net gain/(loss)


292,647



(1,842,912
)


(1,141,119
)Currency exchange gain/(loss)


-



-



-Comprehensive gain/(loss)

$
292,647


$
(1,842,912
)

$
(1,141,119
)Net Gain/(Loss) per share

$
0.006


$
(0.036
)

$
(0.023
)Net Comprehensive Gain/(Loss) per share

$
0.006


$
(0.036
)

$
(0.023
)Weighted average common shares outstanding


51,063,319



50,966,606



50,413,319













23
 Table of Contents








DRAGON JADE INTERNATIONAL LIMITED





Consolidated Statements of Changes in Stockholders' Equity





Common


Retained


Other


TotalCommon


Shares To Be


Earnings


Comprehensive


Stockholders'Shares


Stock


Issued


(Deficit)


Income


Equity (Deficit)Balance, March 31, 2012


30,410,000


$
158,266


$
-


$
(158,266
)

$
-


$
-Net loss for the year


-



-







(181,122
)


-



(181,122
)Issuance of Stock


20,003,319



291,573



-



-



-



291,573Balance, March 31, 2013


50,413,319



449,839



-



(339,388
)


-



110,451Net loss for the year


-



-



-



(1,141,119
)


-



(1,141,119
)Shares to be issued


-



-



430,000



-



-



430,000Balance, March 31, 2014


50,413,319



449,839



430,000



(1,480,507
)


-



(600,668
)Net loss for the year


-



-



-



(1,842,912
)


-



(1,842,912
)Issuance of Stock


650,000



654,122



(430,000
)


-



-



224,122Balance, March 31, 2015


51,063,319



1,103,961



-



(3,323,419
)


-



(2,219,458
)Net gain for the year


-



-



-



292,647



-



292,647Issuance of Stock


-



-



-



-



-



-Balance, March 31, 2016


51,063,319



1,103,961



-



(3,030,772
)


-



(1,926,811
)

















24
 Table of Contents








DRAGON JADE INTERNATIONAL LIMITED





Cash Flow Statement





For the Years Ended March 31,2016


2015


2014Cash flows from operating activitiesNet gain / (loss)

$
292,647


$
(1,842,912
)

$
(1,141,119
)Adjustments to reconcile net income/(loss) to  net cash used in operating activities:Depreciation


4,068



1,104



1,086Non-controlling interest


(4,763
)


(6,158
)


(7,008
)Changes in assets and liabilities:Deposits and other receivables


(8,046
)


415



4,610Account receivables


(25,489
)


33,109



(44,063
)Inventory


(190,042
)


13,353



1,953Deferred tax assets


-



-



226,016Accounts payables


9,381



(2,063
)


(1,499
)Accrued liabilities and other payables-Third party


19,221



(30,704
)


18,033Amount due to directors


677,821



37,454



(28,514)Convertible promissory notes


(760,000
)


1,383,992



720,130Net cash (used in) operating activities


14,798



(412,410
)


(250,375
)Cash flow from investing activitiesAcquisition of assets


(25,128
)


-



(1,759
)Net cash (used in) investing activities


(25,128
)


-



(1,759
)Cash flow from financing activitiesCash for issuance of shares


-



20,000



430,000Net cash provided by financing activities


-



20,000



430,000Effect of foreign exchange rate  changes  on cash and cash equivalent






-



-Cash and cash equivalents:Net (decrease) increase


(10,330
)


(392,410
)


177,866Balance at beginning of period


29,136



421,546



243,680Balance at end of period


18,806



29,136



421,546Supplemental cash flow information:Cash paid for income taxes


-



-



-Cash paid for interest

$
-


$
-


$
-
















25
 Table of Contents








DRAGON JADE INTERNATIONAL LIMITED





NOTES TO CONSOLIDATED FINANCIAL STATEMENTS








1. The Company





Dragon Jade International Limited (the “Company”) was incorporated on April 14, 2008 in the British Virgin Islands.  The principal activity of the Company is investment holding.





In April 2012, the Company chartered a new subsidiary, Alpha Ultimate Limited under the laws of the Special Administrative Region of Hong Kong which operates in the health supplement industry.





On August 31, 2012 the Company entered into a stock exchange agreement with United Century Holdings Limited, a privately held corporation.  On September 1 2012, the Company consummated the transaction contemplated by the stock exchange agreement.  All of the capital stock of United Century Holdings Limited was exchanged for an aggregate of 20,003,319 shares of the Company’s capital stock.  The Company became a 100% holding company of United Century Holdings Limited.





United Century Holdings Limited (“UCHL”) was incorporated on March 2, 2012 under the British Virgin Islands Business Companies Act, 2004 with limited liabilities.  UCHL is established as a special purpose holding company whose objective is to become a holding company by consummate an acquisition, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more business located in Hong Kong.  On July 10, 2012, UCHL executed an acquisition of 7,879,500 out of 8,000,000 ordinary shares, par value $0.1282 (HK$1) per share, of the United Asia Medical Network Company Limited (“UAM”) and became a 98.49% holding company of UAM.





UAM was incorporated on May 6, 1998 as a limited liability company under Hong Kong Companies Ordinance, Chapter 32.  Its principal business is trading of health supplement products and providing related medical and health consultancy services.





Details of the Company’s subsidiaries (which together with the Company are collectively referred to as the “Group”) and their principal activity as of March 31, 2016 were as follows:





Name

Date of

incorporation/

establishment

Place of

incorporation/

registration and

operation

Percentage of

equity interest

attributable to

the Company


Principal activitiesAlpha Ultimate Ltd. ("AUL")

April 11, 2012

Hong Kong


100
%

Health supplement tradingUnited Century Holdings Ltd. (“UCHL”)

March 2, 2012

BVI


100
%

Investment holdingUnited Asia Medical Network Company Limited (“UAM”)

May 6, 1998

Hong Kong


98.49
%

Health supplement trading
















26
 Table of Contents








2. Summary of Significant Accounting Policies





(a) Basis of Consolidation





The accompanying consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America.





The consolidated financial statements include the accounts of the Company and its subsidiary. All significant inter-company accounts and transactions have been eliminated in consolidation.





(b) Use of Estimates





In preparing financial statements in conformity with US GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported periods. Significant estimates include depreciation. Actual results could differ from those estimates.





(c) Cash and Cash Equivalents





The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. As of March 31, 2016, the Company did not have any cash equivalents.





(d) Inventories





Inventories are stated at the lower of cost or net realizable value (market value). The cost of raw materials is determined on the basis of weighted average. The cost of finished goods is determined on the weighted average basis and comprises direct materials, direct labor and an appropriate proportion of overhead.





Net realizable value is based on estimated selling prices less any further costs expected to be incurred for completion and selling expense.





(e) Accounts Receivable





Accounts receivable are recognized and carried at net realizable value. An allowance for doubtful accounts will be recorded in the period when a loss is probable based on an assessment of specific evidence indicating troubled collection, historical experience, accounts aging, ongoing business relation and other factors. Accounts are written off after exhaustive efforts at collection. If accounts receivable are to be provided for, or written off, they would be recognized in the consolidated statement of operations within operating expenses. At March 31, 2016, the Company has no allowance for doubtful accounts, as per the management’s judgment based on their best knowledge.





(f) Deposit and prepayments





Deposit and Prepayments represent cash paid in advance to suppliers. As of March 31, 2016, prepayments included cash paid advances to suppliers, and prepaid expenses, such as water and electricity fees.





(g) Plant and Equipment





Plant and equipment is stated at cost. Depreciation is provided principally by use of the straight-line method over the useful lives of the related assets, except for leasehold properties, which are depreciated over the terms of their related leases or their estimated useful lives, whichever is less. Expenditures for maintenance and repairs, which do not improve or extend the expected useful life of the assets, are expensed to operations while major repairs are capitalized.





The estimated useful lives are as follows:





Furniture and fittings
5 yearsComputer equipment
5 years





The gain or loss on disposal of property, plant and equipment is the difference between the net sales proceeds and the carrying amount of the relevant assets, and, if any, is recognized in the statement of operations.






27
 Table of Contents







(h) Impairment of Assets





The Company periodically evaluates the carrying value of long-lived assets to be held and used, including intangible assets subject to amortization, when events and circumstances warrant such a review, pursuant to the guidelines established in FASB ASC 360 Property, Plant, and Equipment (formerly Statement of Financial Accounting Standards (“SFAS”) No. 144). The carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. Losses on long-lived assets to be disposed of are determined in a similar manner, except that fair market values are reduced for the cost to dispose.





(i) Income Taxes





Income taxes are provided on an asset and liability approach for financial accounting and reporting of income taxes. Any tax paid by subsidiaries during the year is recorded. Current tax is based on the profit or loss from ordinary activities adjusted for items that are non-assessable or disallowable for income tax purpose and is calculated using tax rates that have been enacted or substantively enacted at the balance sheet date. Deferred income tax liabilities or assets are recorded to reflect the tax consequences in future years of differences between the tax basis of assets and liabilities and the financial reporting amounts at each year end.





A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.





(j) Revenue Recognition





Revenues represent the invoiced value of goods sold recognized upon the shipment of goods to customers. Revenues are recognized when all of the following criteria are met:





●
Persuasive evidence of an arrangement exists;●
Delivery has occurred or services have been rendered;●
The seller’s price to the buyer is fixed or determinable; and●
Collectability is reasonably assured.





(k) Foreign Currency Transactions





The consolidated financial statements of the Company are presented in United States Dollars (“US$”). Transactions in foreign currencies during the period are translated into US$ at the exchange rates prevailing at the transaction dates. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are translated into US$ at the exchange rates prevailing at that date. All transaction differences are recorded in the income statement.





The accompanying consolidated financial statements are presented in United States dollars (US$). The Company’s subsidiary in Hong Kong has its local currency, Hong Kong Dollars (“HK$”), as its functional currency.  On consolidation, the financial statements of the Company’s subsidiary in Hong Kong is translated from HK$ into US$ in accordance with FASB ASC Topic 830 Foreign Currency Matters (formerly SFAS No. 52, "Foreign Currency Translation").  During 2014, 2015 and 2016, the Hong Kong dollars are translated from HK$ with a ratio of US$1.00=HK$7.80, a fixed exchange rate maintained between Hong Kong and United States derived from the Hong Kong Monetary Authority pegging HK$ and US$ monetary policy. Accordingly, all assets and liabilities are translated at the exchange rates prevailing at the balance sheet dates and all income and expenditure items are translated at the average rates for each of the period. Translation of amounts from HK$ into US$ has been made at the following exchanges rates for the respective periods:





March 31, 2016,

2015

and 2014Twelve months ended


7.8HKD:USD exchange rateAverage twelve months ended


7.8HKD:USD exchange rate









28
 Table of Contents








(l) Fair Value of Conversion Features





In accordance with FASB ASC 815 Derivatives and Hedging, the conversion feature of the Convertible Notes is separated from the debt instrument and accounted for separately as a derivative instrument. On the date the Convertible Notes are issued, the conversion feature was recorded as a liability at its fair value, with future decreases in fair value recognized as earnings and increases in fair values recognized as expenses.





The Company used the Black-Scholes-Merton option-pricing model to obtain the fair value of the conversion feature. The Company’s expected volatility assumption is based on the historical volatility of the Company’s stock. The expected life assumption is primarily based on the expiration date of the conversion features. The risk-free interest rate for the expected term of the conversion features is based on the U.S. Treasury yield curve in effect at the time of measurement.





(m) Earnings/(Losses) Per Share





Basic losses per share is computed by dividing the earnings for the year by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution of securities by including other potential common stock, including stock options and warrants, in the weighted average number of common shares outstanding for a period, if dilutive.





(n) Accumulated Other Comprehensive Income





Comprehensive income is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Comprehensive income includes net income and the foreign currency translation changes for the year in which such are obtained.





(o) Stock-Based Compensation





We account for stock-based compensation in accordance with FASB ASC 718 Compensation – Stock Compensation which requires that companies account for awards of equity instruments issued to employees under the fair value method of accounting and recognize such amounts in their statements of operations. Under FASB ASC 718 we are required to measure compensation costs for all stock-based awards at fair value on the date of grant and recognize compensation expense in our consolidated statements of operations over the service period that the awards are expected to vest.





(p) Equity-Based Payments to Non-employees





The Company accounts for equity-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505-50, Equity-Based Payments to Non-Employees that are issued to Other Than Employees for Acquiring or in Conjunction with Selling Goods or Services. If the fair value of goods or services received in a share-based payment transaction with nonemployees is more reliably measureable than the fair value of the equity instruments issued, the fair value of the goods or services received shall be used to measure the transaction. In contrast, if the fair value of the equity instruments issued in a share-based payment transaction with nonemployees is more reliably measured than the fair value of the consideration received, the transaction shall be measured based on the fair value of the equity instruments issued.





(q) Going Concern





As shown in the accompanying consolidated financial statements, the Company has an accumulated deficit of $3,030,772 as of March 31, 2016. The Company will be required to raise additional capital to fund its operations, and will continue to attempt to raise capital resources from both related and unrelated parties until such time as the Company is able to generate revenues sufficient to maintain itself as a viable entity. These factors have raised substantial doubt about the Company's ability to continue as a going concern. There can be no assurances that the Company will be able to raise additional capital or achieve profitability. These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.





The Company plans to strengthen its core business, control its overall expenditures, improve the efficiency of its operations and continue its efforts to expand by exploring additional product lines and market opportunities.








29
 Table of Contents








(r) New Accounting Pronouncements





The FASB has issued Accounting Standards Update (ASU) No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. The amendments in the ASU change the criteria for reporting discontinued operations while enhancing disclosures in this area. It also addresses sources of confusion and inconsistent application related to financial reporting of discontinued operations guidance in U.S. GAAP. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Those strategic shifts should have a major effect on the organization’s operations and financial results. Examples include a disposal of a major geographic area, a major line of business, or a major equity method investment. In addition, the new guidance requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. The new guidance also requires disclosure of the pre-tax income attributable to a disposal of a significant part of an organization that does not qualify for discontinued operations reporting. This disclosure will provide users with information about the ongoing trends in a reporting organization’s results from continuing operations. The amendments in this ASU enhance convergence between U.S. GAAP and International Financial Reporting Standards (IFRS). Part of the new definition of discontinued operation is based on elements of the definition of discontinued operations in IFRS 5, Non-Current Assets Held for Sale and Discontinued Operations. The amendments in the ASU are effective in the first quarter of 2015 for public organizations with calendar year ends. For most nonpublic organizations, it is effective for annual financial statements with fiscal years beginning on or after December 15, 2014. Early adoption is permitted. The Company does not expect ASU 2014-08 to have a significant impact on its results of operations and financial condition.





The FASB has issued Accounting Standards Update (ASU) No. 2014-11, Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, which changes the accounting for repurchase-to-maturity transactions and repurchase financing arrangements. It also requires additional disclosures about repurchase agreements and other similar transactions. According to the FASB, the new guidance aligns the accounting for repurchase-to-maturity transactions and repurchase agreements executed as a repurchase financing with the accounting for other typical repurchase agreements. Going forward, these transactions would all be accounted for as secured borrowings. The guidance eliminates sale accounting for repurchase-to-maturity transactions and supersedes the guidance under which a transfer of a financial asset and a contemporaneous repurchase financing could be accounted for on a combined basis as a forward agreement, which has resulted in outcomes referred to as off-balance-sheet accounting. ASU 2014-11 also brings U.S. GAAP into greater alignment with IFRS for repurchase-to-maturity transactions. The amendments in the ASU require a new disclosure for transactions economically similar to repurchase agreements in which the transferor retains substantially all of the exposure to the economic return on the transferred financial assets throughout the term of the transaction. The amendments in the ASU also require expanded disclosures about the nature of collateral pledged in repurchase agreements and similar transactions accounted for as secured borrowings. The amendments in this ASU are effective for public companies for the first interim or annual period beginning after December 15, 2014. In addition, for public companies, the disclosure for certain transactions accounted for as a sale is effective for the first interim or annual period beginning on or after December 15, 2014, and the disclosure for transactions accounted for as secured borrowings is required to be presented for annual periods beginning after December 15, 2014, and interim periods beginning after March 15, 2015. For all other entities, all changes are effective for annual periods beginning after December 15, 2014, and interim periods beginning after December 15, 2015. Earlier application for a public company is prohibited, but all other companies and organizations may elect to apply the requirements for interim periods beginning after December 15, 2014. The Company does not expect ASU 2014-11 to have a significant impact on its results of operations and financial condition.





The FASB has issued Accounting Standards Update (ASU) No. 2014-17, Business Combinations (Topic 805): Pushdown Accounting (a consensus of the FASB Emerging Issues Task Force). The amendments in this ASU apply to the separate financial statements of an acquired entity and its subsidiaries that are a business or nonprofit activity (either public or nonpublic) upon the occurrence of an event in which an acquirer (an individual or an entity) obtains control of the acquired entity. The amendments in this ASU provide an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in which the change-in-control event occurs. An acquired entity should determine whether to elect to apply pushdown accounting for each individual change-in-control event in which an acquirer obtains control of the acquired entity. If pushdown accounting is not applied in the reporting period in which the change-in-control event occurs, an acquired entity will have the option to elect to apply pushdown accounting in a subsequent reporting period to the acquired entity’s most recent change-in-control event. An election to apply pushdown accounting in a reporting period after the reporting period in which the change-in-control event occurred should be considered a change in accounting principle. If pushdown accounting is applied to an individual change-in-control event, that election is irrevocable. If an acquired entity elects the option to apply pushdown accounting in its separate financial statements, it should disclose information in the current reporting period that enables users of financial statements to evaluate the effect of pushdown accounting. The amendments in this ASU are effective on November 18, 2014. After the effective date, an acquired entity can make an election to apply the guidance to future change-in-control events or to its most recent change-in-control event. However, if the financial statements for the period in which the most recent change-in-control event occurred already have been issued or made available to be issued, the application of this guidance would be a change in accounting principle. The Company does not expect ASU 2014-17 to have a significant impact on its results of operations and financial condition.






30
 Table of Contents








The FASB has issued ASU No. 2015-05 about Intangibles-Goodwill and Other-Internal-Use Software. The objective is to provide a guidance about whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a software license, then the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the customer should account for the arrangement as a service contract. The amendment will not change GAAP for a customer’s accounting for service contracts. In addition, the guidance in this Update supersedes paragraph 350-40-25-16. Consequently, all software licenses within the scope of Subtopic 350-40 will be accounted for consistent with other licenses of intangible assets. For public business entities, the Board decided that the amendments will be effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. For all other entities, the amendment will be effective for annual periods beginning after December 15, 2015, and interim periods in annual periods beginning after December 15, 2016. Early adoption is permitted for all entities.





The FASB has issued Accounting Standards Update (“ASU”) No. 2015-01 about Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items. The objective is to reduce the cost and complexity of income statement presentation by eliminating the concept of extraordinary items while maintaining or improving the usefulness of the information provided to the users of financial statements. The extraordinary items must met two criteria’s: unusual nature and infrequency of occurrence. If an event or transaction meets the criteria for extraordinary classification, an entity is required to segregate the extraordinary item from the results of ordinary operations and show the item separately in the income statement, net of tax, after income from continuing operations. The entity also is required to disclose applicable income taxes and either. This amendment will be effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2015. The Board decided to permit early adoption provided that the guidance is applied from the beginning of the fiscal year of adoption.





The FASB has issued ASU No. 2015-03 about Simplifying the Presentation of Debt Issuance Costs. The objective is to require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this Update. For public business entities, the amendments in this Update are effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. For all other entities, the amendments in this Update are effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within fiscal years beginning after December 15, 2016. Early adoption of the amendments in this Update is permitted for financial statements that have not been previously issued.





The FASB has issued ASU No. 2015-06 about Topic 260, Earnings Per Share, which contains guidance that addresses master limited partnerships that originated from Emerging Issues Task Force (EITF) Issue No. 07-4. This amendment in this Update specify that for purposes of calculating historical earnings per unit under the two-class method, the earnings (losses) of a transferred business before the date of a dropdown transaction should be allocated entirely to the general partner. In that circumstance, the previously reported earnings per unit of the limited partners (which is typically the earnings per unit measure presented in the financial statements) would not change as a result of the dropdown transaction. Qualitative disclosures about how the rights to the earnings (losses) differ before and after the dropdown transaction occurs for purposes of computing earnings per unit under the two-class method also are required. The amendments in this Update are effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Earlier application is permitted.





The FASB has issued ASU No. 2015-07 about Topic 820, Fair Value Measurement, which permits a reporting entity, as a practical expedient, to measure the fair value of certain investments using the net asset value per share of the investment. The amendments in this Update remove the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The amendments also remove the requirement to make certain disclosures for all investments that are eligible to be measured at fair value using the net asset value per share practical expedient. Rather, those disclosures are limited to investments for which the entity has elected to measure the fair value using that practical expedient. The amendments in this Update apply to reporting entities that elect to measure the fair value of an investment within the related scope by using the net asset value per share (or its equivalent) practical expedient.





The FASB has issued Accounting Standards Update (ASU) No. 2015-10, Technical Corrections and Improvements Related to Glossary Terms. The amendments in this ASU relate to glossary terms and cover a wide range of Topics in the FASB’s Accounting Standards CodificationTM (Codification). These amendments are presented in four sections:





1. Deletion of Master Glossary Terms (Section A) arising because of terms that were carried forward from source literature (e.g., FASB Statements, EITF Issues, and so forth) to the Codification but were not utilized in the Codification.






31
 Table of Contents








2. Addition of Master Glossary Term Links (Section B) arising from Master Glossary terms whose links did not carry forward to the Codification.





3. Duplicate Master Glossary Terms (Section C) arising from Master Glossary terms that appear multiple times in the Master Glossary with similar, but not identical, definitions.





4. Other Technical Corrections Related to Glossary Terms (Section D) arising from miscellaneous changes to update Master Glossary terms.


The amendments do not have transition guidance and are effective upon issuance for both public entities and nonpublic entities.





Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption.





The Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on results of operations, financial condition, or cash flows, based on current information.




3.  Income Taxes
 
 BRITISH VIRGIN ISLANDS
 The Company was incorporated in the British Virgin Islands and, under the current laws of the British Virgin Islands, is not subject to income taxes.
 
 HONG KONG
 No Hong Kong Profits Tax has been provided in the financial statements as Alpha Ultimate Ltd had sufficient unused tax loss brought forward to offset against the assessable profits for the year and United Asia Medical Network Co Ltd was in a tax loss position during the year.
  4.  Retirement and Welfare Benefits





The employees of the Company are members of the Mandatory Provident Fund operated by the Hong Kong government. The company contributes 5% according to the different payroll range of the employee, and the maximum amount of contribution is up to $192 (HK$1,500) per month.





5.  Cash and Bank Deposit





Cash and cash equivalents are summarized as follows:


2016


2015Cash at Bank

$
18,124


$
28,676Cash on Hand


682



460Total

$
18,806


$
29,136





6. Trade Receivables, Net





Trade receivables comprise the followings:


2016


2015Trade receivables, gross

$
40,492


$
15,003Provision for doubtful debts


-



-Trade receivables, net

$
40,492


$
15,003





All of the above trade receivables are due within one year of aging.





Allowance was made when collection of the full amount is no longer probable.  Management reviews and adjusts this allowance periodically based on historical experience, current economic climate as well as its evaluation of the collectability of outstanding accounts. The Group evaluates the credit risks of its customers utilizing historical data and estimates of future performance.






32
 Table of Contents








7.  Inventories





Inventories comprise the followings:


2016


2015Finished goods

$
191,992


$
1,950$
191,992


$
1,950





8. Property, Plant and Equipment, Net





Property, plant and equipment, net comprise the followings:


2016


2015At costLeasehold improvement, furniture and office equipment

$
30,895


$
5,767$
30,895


$
5,767Less: accumulated depreciation


(6,812
)


(2,744
)$
24,083


$
3,023





Depreciation expenses are included in the statement of income as follows:


2016


2015Selling, general and administrative

$
4,068


$
1,104Total depreciation expenses

$
4,068


$
1,104





9.  Income Taxes





The Company, including the holding company Dragon Jade International Limited and intermediate holding company United Century Holdings Ltd., is being registered in the British Virgin Islands and which conducts all of its business through its subsidiaries incorporated in Hong Kong, is not subject to federal income tax until the operating profits was rebounded back to Untied States. The subsidiaries are Alpha Ultimate Ltd, and United Asia Medical Network Co Ltd (see note 1).





Alpha Ultimate Ltd, and United Asia Medical Network Co Ltd, being registered in the Hong Kong, are subject to HK’s Profit Tax (“HKPT”). Under applicable income tax laws and regulations, an enterprise located in Hong Kong, including the district where our operations are located, is subject to a rate of 16.5% for the years ended March 31, 2016.





The Group uses the asset and liability method, where deferred tax assets and liabilities are determined based in the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes.





A reconciliation between the income tax computed at the U.S. statutory rate and the Group’s provision for income tax is as follows:


2016


2015HKPT


16.5
%


16.5
%Provision for income taxes


16.5
%


16.5
%








10. Related Party Transactions





Since April 1, 2012, there has been no related party transaction, except the amount of $729,609 due LAI Yat Man for funds advanced to the Company, AUL and UAM, which amount has no collateral, due date or maturity date and does not accrue any interest.






33
 Table of Contents








11. Concentrations and Credit Risk





The Company operates principally in Hong Kong and grants credit to its customers in this geographic region. Hong Kong has a relatively stable economy. However, it is always possible that unanticipated events in foreign countries could disrupt the Company’s operations.





Financial instruments that potentially subject the Group to a concentration of credit risk consist of cash and accounts receivable.





The Company does not require collateral to support financial instruments that are subject to credit risk.





12. Commitments and Contingencies





As of March 31, 2016 and 2015, the company did not have any contingent liabilities.





13. Acquisition





On August 31, 2012 the Company entered into a stock exchange agreement with United Century Holdings Limited, a privately held corporation. On September 1 2012, the Company consummated the transaction contemplated by the stock exchange agreement. All of the capital stock of United Century Holdings Limited was exchanged for an aggregate of 20,003,319 shares of the Company’s capital stock. The Company became a 100% holding company of United Century Holdings Limited.





United Century Holdings Limited (“UCHL”) owns 98.49% equity interest in United Asia Medical Network Company Limited (“UAM”). UAM was incorporated on May 6, 1998 as a limited liability company under Hong Kong Companies Ordinance, Chapter 32. Its principal business is trading of health supplement products and providing related medical and health consultancy services.





The Company accounted for this acquisition of UCHL and its subsidiaries by acquisition method of accounting. The balance sheet items were stated at cost.





The purchase price was allocated as follows:





Purchase Consideration:Acquisition obligation payable to sellers

$
291,573Assets AcquiredNet tangible assets acquired:Fixed assets

$
3,266Inventories


8,834Trade receivables, deposits, prepayment and other receivables


30,752Deferred taxation


200,163Cash


61,731Trade payables, other creditors and accruals


(13,173
)Net tangible assets acquired

$
291,573Purchase consideration in excess of net tangible assets

$
---Allocated to:Goodwill


---$
---





UCHL’s results of operations are consolidated with the Company effective September 1, 2012.








34
 Table of Contents








14.  CONVERTIBLE PROMISSORY NOTES





On December 31, 2012, the Company issued its convertible promissory note in the amount of $300,000 for additional working capital. The note is due December 31, 2013 and carries interest at 10 percent per annum, payable quarterly. The note is convertible into common stock of the Company at any time before maturity, at the election of the Holder, at the rate of $0.50 per share.  On April 12, 2016, this Convertible Note was fully converted into 600,000 shares of our common stock. The outstanding principal of $300,000 was converted into 600,000 shares of our common stock at an exercise price of $0.50 per share in a transaction exempt from the registration and prospectus delivery requirements of the Securities Act of 1933.





On April 1, 2013, the Company issued its convertible promissory note in the amount of $100,000 for additional working capital. The note is due April 1, 2014 and carries interest at 10 percent per annum, payable quarterly. The note is convertible into common stock of the Company at any time before maturity, at the election of the Holder, at the rate of $0.50 per share.  On March 31, 2014, the convertible note in the amount of $100,000 was matured.  No new agreement had been reached.  There was $9,640 of interest charged on the matured loan of $100,000.





The fair value of the convertible promissory note was calculated using the Black-Scholes valuation method. The following assumptions provide information regarding the fair value of convertible promissory notes issued as of March 31, 2016:


March 31, 2016Common stock issuable upon conversion


800,000Market value of common stock on measurement date (1)

$
2.30Exercise price

$
0.50Risk free interest rate (2)


18
%Term in year


0.00Expected volatility (3)


38.2
%Expected dividend yield (4)


0
%





(1)
The market value of common stock is the stock price at the close of trading on the date of March 31, 2016.





(2)
The risk-free interest rate was determined by management using the Treasury Bill rates as of March 31, 2016.





(3)
Expected volatility is based on average volatility of historical share trade information. The Company believes this method produces an estimate that is representative of the Company’s expectations of future volatility over the expected term of the warrants.





(4)
Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.





Fair Value on a Recurring Basis





The following table sets forth, by level within the fair value hierarchy, the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2016:





Fair Value Measurements at March 31, 2016Quoted Prices In Active Markets for


Significant Other


Significant

Unobservable


Total CarryingIdentical Assets


Observable Inputs


Inputs


Value as ofDescriptions

(Level 1)


(Level 2)


(Level 3)


March 31, 2016Derivative warrant instruments

$
-


$
-


$
1,440,000


$
1,440,000Total

$
-


$
-


$
1,440,000


$
1,440,000










35
 Table of Contents








15. SEGMENT INFORMATION





The Company is operating in one geographic location and one product category, therefore, segment information is not required to be provided.





16.   SUBSEQUENT EVENTS





On May 5, 2016 the Company entered into a memorandum of understanding with Ultroid Marketing Development Corporation (“UMDC”) for a proposed definitive agreement to be signed within one hundred and twenty days in which the Company acquires one hundred percent interest in UMDC.  The contemplated definitive agreement proposes the Company to acquire UMDC for $40,000,000 in a combination of cash and DGJI common stock.


































36